{"transactions":[{"id":879586,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-26T07:02:37.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39011,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39011},"source":{"system":"sec-edgar","filing":"0001999371-26-004387","document":"sullivan-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937126004387/sullivan-form4_022626.xml","form_type":"4"}},{"id":879585,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-02-26T07:02:37.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39012,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39012},"source":{"system":"sec-edgar","filing":"0001999371-26-004387","document":"sullivan-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937126004387/sullivan-form4_022626.xml","form_type":"4"}},{"id":1240649,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-02-27T18:49:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29017,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29017},"source":{"system":"sec-edgar","filing":"0001839882-25-011955","document":"sullivan_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988225011955/sullivan_form4-022725.xml","form_type":"4"}},{"id":1240648,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2025-02-27T18:49:35.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29017,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29017,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29017},"source":{"system":"sec-edgar","filing":"0001839882-25-011955","document":"sullivan_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988225011955/sullivan_form4-022725.xml","form_type":"4"}},{"id":1240647,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2025-02-27T18:49:35.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":0.11,"price":1.47,"value":0.1617,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Involuntary sale of fractional shares following a reverse stock split of the Issuer's common stock"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011955","document":"sullivan_form4-022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988225011955/sullivan_form4-022725.xml","form_type":"4"}},{"id":1609974,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2024-02-29T17:05:49.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":358000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":358000,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":358000},"source":{"system":"sec-edgar","filing":"0001999371-24-002949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937124002949/ownership.xml","form_type":"4"}},{"id":1609973,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2024-02-29T17:05:49.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":358000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":358000,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":358000},"source":{"system":"sec-edgar","filing":"0001999371-24-002949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000199937124002949/ownership.xml","form_type":"4"}},{"id":1993166,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2023-02-24T18:38:05.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":220000,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001839882-23-004704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988223004704/ownership.xml","form_type":"4"}},{"id":1993165,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2023-02-24T18:38:05.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":220000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":220000,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":220000},"source":{"system":"sec-edgar","filing":"0001839882-23-004704","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000183988223004704/ownership.xml","form_type":"4"}},{"id":2388473,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-02-17T17:19:49.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":1250000,"derivative":{"exercise_price":0.828,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001387131-22-002108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713122002108/ownership.xml","form_type":"4"}},{"id":2388472,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-02-17T17:19:49.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":1250000,"derivative":{"exercise_price":0.621,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001387131-22-002108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713122002108/ownership.xml","form_type":"4"}},{"id":2388471,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-02-17T17:19:49.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":1250000,"derivative":{"exercise_price":0.414,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001387131-22-002108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713122002108/ownership.xml","form_type":"4"}},{"id":2388470,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2022-02-17T17:19:49.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":1250000,"derivative":{"exercise_price":0.207,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1250000},"source":{"system":"sec-edgar","filing":"0001387131-22-002108","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713122002108/ownership.xml","form_type":"4"}},{"id":2401604,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2022-02-11T17:17:18.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":36496,"price":0.58,"value":21167.68,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2020 Employee Stock Purchase Plan."}],"balance_after":99223,"source":{"system":"sec-edgar","filing":"0001387131-22-001714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713122001714/ownership.xml","form_type":"5"}},{"id":2832751,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-02-25T17:47:28.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":750000,"derivative":{"exercise_price":1.53,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001387131-21-002884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713121002884/ownership.xml","form_type":"4"}},{"id":2832750,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2021-02-25T17:47:28.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":750000,"derivative":{"exercise_price":1.22,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0001387131-21-002884","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713121002884/ownership.xml","form_type":"4"}},{"id":2832749,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2021-02-25T17:47:28.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":41322,"price":0.51,"value":21074.22,"ownership":{"direct":true},"footnotes":[{"field":"timeliness","element":"transactionTimeliness","label":"F1","text":"The shares were purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan and are not required to be filed on a Form 4."}],"balance_after":62727,"source":{"system":"sec-edgar","filing":"0001387131-21-002884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713121002884/ownership.xml","form_type":"4"}},{"id":3052359,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2020-08-19T09:02:24.000Z","date":"2020-08-17","kind":"purchase","acquired":true,"shares":20000,"price":1.03,"value":20600.0,"ownership":{"direct":true},"balance_after":21405,"source":{"system":"sec-edgar","filing":"0001387131-20-007672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713120007672/ownership.xml","form_type":"4"}},{"id":3159541,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2020-05-06T18:24:43.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":500000,"derivative":{"exercise_price":0.96,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001387131-20-004483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713120004483/ownership.xml","form_type":"4"}},{"id":3159540,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2020-05-06T18:24:43.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":500000,"derivative":{"exercise_price":0.77,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001387131-20-004483","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713120004483/ownership.xml","form_type":"4"}},{"id":3243913,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2020-02-27T16:23:08.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":39000,"derivative":{"exercise_price":0.5,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001387131-20-002255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713120002255/ownership.xml","form_type":"4"}},{"id":3243912,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2020-02-27T16:23:08.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":39000,"derivative":{"exercise_price":0.4,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":39000},"source":{"system":"sec-edgar","filing":"0001387131-20-002255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713120002255/ownership.xml","form_type":"4"}},{"id":3270695,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2020-02-14T16:15:41.000Z","date":"2019-07-31","kind":"grant","acquired":true,"shares":1142,"price":11.82,"value":13498.44,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2019 Employee Stock Purchase Plan."}],"balance_after":1405,"source":{"system":"sec-edgar","filing":"0001387131-20-001794","document":"sullivan-form5_123119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713120001794/sullivan-form5_123119.xml","form_type":"5"}},{"id":3270694,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.001","published_at":"2020-02-14T16:15:41.000Z","date":"2019-02-17","kind":"grant","acquired":true,"shares":59,"price":17.85,"value":1053.15,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. 2018 Employee Stock Purchase Plan."}],"balance_after":1405,"source":{"system":"sec-edgar","filing":"0001387131-20-001794","document":"sullivan-form5_123119.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713120001794/sullivan-form5_123119.xml","form_type":"5"}},{"id":3535225,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2019-05-08T08:01:25.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":43252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":43252,"derivative":{"exercise_price":2.56,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":43252},"source":{"system":"sec-edgar","filing":"0001387131-19-003427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713119003427/ownership.xml","form_type":"4"}},{"id":3535224,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2019-05-08T08:01:25.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":43253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":43253,"derivative":{"exercise_price":2.05,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":43253},"source":{"system":"sec-edgar","filing":"0001387131-19-003427","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713119003427/ownership.xml","form_type":"4"}},{"id":3629051,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2019-02-27T17:33:55.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":7755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":7755,"derivative":{"exercise_price":2.36,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":7755},"source":{"system":"sec-edgar","filing":"0001387131-19-001530","document":"sullivan-form4_02262019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713119001530/sullivan-form4_02262019.xml","form_type":"4"}},{"id":3629050,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2019-02-27T17:33:55.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":7755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":7755,"derivative":{"exercise_price":1.89,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":7755},"source":{"system":"sec-edgar","filing":"0001387131-19-001530","document":"sullivan-form4_02262019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000138713119001530/sullivan-form4_02262019.xml","form_type":"4"}},{"id":3892592,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-15T07:05:32.000Z","date":"2018-06-14","kind":"purchase","acquired":true,"shares":10000,"price":3.965,"value":39650.0,"ownership":{"direct":true},"balance_after":20482,"source":{"system":"sec-edgar","filing":"0001615774-18-005327","document":"s110851_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000161577418005327/s110851_form4.xml","form_type":"4"}},{"id":4054906,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2018-02-15T16:09:12.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":58725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":58725,"derivative":{"exercise_price":4.25,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":58725},"source":{"system":"sec-edgar","filing":"0001615774-18-001264","document":"s109081_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000161577418001264/s109081_form4.xml","form_type":"4"}},{"id":4054905,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2018-02-15T16:09:12.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":58726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":58726,"derivative":{"exercise_price":3.4,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":58726},"source":{"system":"sec-edgar","filing":"0001615774-18-001264","document":"s109081_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000161577418001264/s109081_form4.xml","form_type":"4"}},{"id":4414168,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2017-03-01T21:19:52.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2016 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 50% if the Issuer achieves enrollment of 250 patients in its HONOR study by December 31, 2017, with the remaining 50% vesting 1% for each patient that is enrolled in the HONOR study by December 31, 2017 in excess of 250, subject to a one year minimum service period prior to vesting."}],"balance_after":75000,"derivative":{"exercise_price":0.55,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001615774-17-000856","document":"s105457_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000161577417000856/s105457_form4.xml","form_type":"4"}},{"id":4414167,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2017-03-01T21:19:52.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2016 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":75000,"derivative":{"exercise_price":0.55,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001615774-17-000856","document":"s105457_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000161577417000856/s105457_form4.xml","form_type":"4"}},{"id":4453953,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64476,"kind":"person","name":"SULLIVAN GREGORY M","position":1,"cik":"0001610106","reported_name":"SULLIVAN GREGORY M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2017-02-13T09:52:48.000Z","date":"2016-06-30","kind":"other","acquired":true,"shares":3296,"price":1.74,"value":5735.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired through the Tonix Pharmaceuticals Holding Corp. Employee Stock Purchase Plan."}],"balance_after":46481,"source":{"system":"sec-edgar","filing":"0001615774-17-000521","document":"s105312_form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1610106/000161577417000521/s105312_form5.xml","form_type":"5"}}]}